The Latest Breaking News from Ro

Jameela Jamil finds it "uncomfortable" seeing Serena Williams promote the use of weight-loss medication.

COMMENT: As a Black woman in a white-dominated sport, Williams experienced unique pressures. Yet to see someone of her calibre promoting weight-loss drugs shows an unnerving societal shift, writes the body image campaigner Alex Light

Fellow Health just raised $24 million in a Series B funding round, bringing its cash haul across multiple offerings to $48 million. The San Leandro, California startup advances male reproductive health through "patient-centric testing solutions" and plans to use the capital infusion to expand its mail-in semen analysis services.  

The Russian Community group has soared in popularity, with its focus on promoting the needs of ‘ethnic Russians’.

Novo Nordisk ended its partnership with Hims & Hers on 23 June 2025, accusing the telehealth firm of selling unsafe, unapproved Wegovy knock-offs. Hims' stock tanked, and legal risks loom.

The move comes as Danish drugmaker Novo Nordisk has acted to slash the popular weight loss drug’s price

New Orleans chef Susan Spicer has been a regular contributor to the Taste of the NFL charity event at Super Bowl host cities around the country and is doing so in her hometown again this year

Noom, Calibrate, and Embla tell customers they can stop taking GLP-1s and keep off the weight they’ve lost. Doctors and drug manufacturers disagree.

As nearly $1 billion of venture capital dollars have been injected into weight-loss startups since 2023, companies are making unproven claims to attract customers. It’s a new twist on a story as old as the diet industry.